Replies to post #194091 on Biotech Values

[DewDiligence]

It is pretty easy to reduce shares outstanding after the deal is closed.

I don’t fully agree; it would take quite a while to repurchase so many shares in the open market.

[DewDiligence]

SHPG investigating tax angles in BXLT offer to circumvent IRS restrictions on quickly funneling cash to shareholders of a tax-free spinoff (what BXLT was):

http://www.wsj.com/articles/shire-weighing-options-to-sweeten-all-stock-offer-for-baxalta-sources-say-1442161034